New Delhi: Diagnostic chain Dr Lal PathLabs reported 27.21 percent rise in consolidated net profit to Rs 40.2 crore for the quarter ended March 31, 2018.
The company had posted a net profit of Rs 31.6 crore during January-March, 2016-17, Dr Lal PathLabs said in a filing to BSE.
Consolidated operating revenue rose to Rs 266.8 crore for the quarter under review. It was Rs 219.9 crore for the same period a year ago.
For entire 2017-18, the company’s net profit rose to Rs 171.8 crore as against Rs 155.6 crore in 2016-17. Consolidated operating revenue for the year stood at Rs 1,056.9 crore. It was Rs 912.4 crore in the previous financial year.
The company’s board has recommended a final dividend of Rs 3 per equity share of Rs 10 each for 2017-18. This is in addition to the interim dividend of Rs 1.50 already paid out, Dr Lal PathLabs said.